Enhancing the clinical value of serum neurofilament light chain measurement is a research paper published in JCI Insight (2022). On theSindex it has a DataRank of 0.780. It has been cited 20 times, with 15 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.457
From this paper's citation signal
Citation Network Contribution
0.323
From 12 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 15 citers.
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH).
Grant: AI001242,AI001243,
National Institutes of Health
Grant: 1ZIAAI001243-05
From therapeutic mechanisms to unraveling the pathophysiology of MS
National Institutes of Health
Grant: 1ZIAAI001242-07
Comprehensive multimodal analysis of patients with neuroimmunological diseases
FWCI
2.46
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Impact of amyloid and cardiometabolic risk factors on prognostic capacity of plasma neurofilament light chain for neurodegeneration
Additional file 1 of Impact of amyloid and cardiometabolic risk factors on prognostic capacity of plasma neurofilament light chain for neurodegeneration